Hanoch Hod

Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

Thrombin Receptor (Protease Activated Receptor-1) Antagonists as Potent Antithrombotic Agents with Strong Antiplatelet Effects

Reference left atrial dimensions and volumes by steady state free precession cardiovascular magnetic resonance

Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects

A comparison of prasugrel and clopidogrel loading doses on platelet function: magnitude of platelet inhibition is related to active metabolite formation

ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Acute Coronary Care in the Elderly, Part I

Intracranial hemorrhage in association with thrombolytic therapy: Incidence and clinical predictive factors

Location of Acute Myocardial Infarction and Associated Arrhythmias and Outcome

Short-Term Effects of Nose-Only Cigarette Smoke Exposure on Glutathione Redox Homeostasis, Cytochrome P450 1A1/2 and Respiratory Enzyme Activities in Mice Tissues

Mechanisms of Thrombus Formation

Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: A risk-benefit analysis

Increased Active Metabolite Formation Explains the Greater Platelet Inhibition With Prasugrel Compared to High-dose Clopidogrel

Relation between renal function, presentation, use of therapies and in‐hospital complications in acute coronary syndrome: data from the SWEDEHEART register

Fourth Universal Definition of Myocardial Infarction (2018)

New P2Y12Inhibitors Versus Clopidogrel in Percutaneous Coronary Intervention

Pretreatment with Prasugrel in Non–ST-Segment Elevation Acute Coronary Syndromes

Universal Definition of Myocardial Infarction

High Residual Platelet Reactivity After Clopidogrel Loading and Long-term Cardiovascular Events Among Patients With Acute Coronary Syndromes Undergoing PCI

Platelet Reactivity After Clopidogrel Treatment Assessed With Point-of-Care Analysis and Early Drug-Eluting Stent Thrombosis

Left atrial size and risk for all-cause mortality and ischemic stroke

Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38)

Prasugrel achieves greater and faster P2Y12receptor-mediated platelet inhibition than clopidogrel due to more efficient generation of its active metabolite in aspirin-treated patients with coronary artery disease

ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”

Ethnicity-related differences in left ventricular function, structure and geometry: a population study of UK Indian Asian and European white subjects

Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis

Circulating Endothelial Progenitor Cells and Cardiovascular Outcomes

Safety, Tolerability, and Initial Efficacy of AZD6140, the First Reversible Oral Adenosine Diphosphate Receptor Antagonist, Compared With Clopidogrel, in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome

Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy

Rivaroxaban in Patients with a Recent Acute Coronary Syndrome

Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirin

Selection of Patients with Acute Myocardial Infarction for Thrombolytic Therapy

Variability in Individual Responsiveness to Clopidogrel

Bivalirudin during Primary PCI in Acute Myocardial Infarction

Cytochrome P-450 Polymorphisms and Response to Clopidogrel

Takotsubo cardiomyopathy: State-of-the-art review

Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of Cardiology

Recommendations for the Standardization and Interpretation of the Electrocardiogram

Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial

Common polymorphisms of CYP2C19 and CYP2C9 affect the pharmacokinetic and pharmacodynamic response to clopidogrel but not prasugrel

Exercise Standards for Testing and Training

A Comparison between Heparin and Low-Dose Aspirin as Adjunctive Therapy with Tissue Plasminogen Activator for Acute Myocardial Infarction

Emergency Hospitalizations for Adverse Drug Events in Older Americans

Cardiac-Resynchronization Therapy for the Prevention of Heart-Failure Events

Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris

The Year in Non-ST-Segment Elevation Acute Coronary Syndromes

Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

Left Atrial Volume Measured by Real-Time 3-Dimensional Echocardiography Predicts Clinical Outcomes in Patients with Severe Left Ventricular Dysfunction and in Sinus Rhythm

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure

Impact of clopidogrel loading dose on clinical outcome in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis

2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)

Liberal or Restrictive Transfusion in High-Risk Patients after Hip Surgery

Universal Definition of Myocardial Infarction

Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention

Role of Prasugrel, a Novel P2Y12 Receptor Antagonist, in the Management of Acute Coronary Syndromes

Platelet Activation and Atherothrombosis

Increased risk of atherothrombotic events associated with cytochrome P450 3A5 polymorphism in patients taking clopidogrel

Electrocardiographic diagnosis of acute myocardial infarction: Current concepts for the clinician

Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease

Determinants of the interindividual variability in response to antiplatelet drugs

Value of the electrocardiogram in localizing the occlusion site in the left anterior descending coronary artery in acute anterior myocardial infarction

The Metabolic Syndrome and Cardiovascular Risk

Use of the Electrocardiogram in Acute Myocardial Infarction

Effect of age on use of thrombolytic therapy and mortality in acute myocardial infarction

Alogliptin after Acute Coronary Syndrome in Patients with Type 2 Diabetes

Cardiorenal Syndrome

Apical ballooning syndrome (Tako-Tsubo or stress cardiomyopathy): A mimic of acute myocardial infarction

Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

The Year in Non–ST-Segment Elevation Acute Coronary Syndrome

Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent era

Testing of Low-Risk Patients Presenting to the Emergency Department With Chest Pain

Role of Magnesium in Reducing Mortality in Acute Myocardial Infarction

The Efficacy and Safety of Prasugrel With and Without a Glycoprotein IIb/IIIa Inhibitor in Patients With Acute Coronary Syndromes Undergoing Percutaneous Intervention

Guidelines for Percutaneous Coronary Interventions

Antiplatelet effects of prasugrel vs. double clopidogrel in patients on hemodialysis and with high on‐treatment platelet reactivity

Patients with circumflex occlusions miss out on reperfusion

Impact of the Degree of Peri-Interventional Platelet Inhibition After Loading With Clopidogrel on Early Clinical Outcome of Elective Coronary Stent Placement

Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2)

Platelet function normalization after a prasugrel loading‐dose: time‐dependent effect of platelet supplementation

Influence of Omeprazole on the Antiplatelet Action of Clopidogrel Associated With Aspirin

Interindividual variability in the response to oral antiplatelet drugs: a position paper of the Working Group on antiplatelet drugs resistance appointed by the Section of Cardiovascular Interventions of the Polish Cardiac Society, endorsed by the Working Group on Thrombosis of the European Society of Cardiology

Comparison of ticagrelor, the first reversible oral P2Y12 receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) trial

Clopidogrel Loading Dose (300 Versus 600 mg) Strategies for Patients With Stable Angina Pectoris Subjected to Percutaneous Coronary Intervention

Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin-treated patients with stable coronary artery disease

Tailored Clopidogrel Loading Dose According to Platelet Reactivity Monitoring to Prevent Acute and Subacute Stent Thrombosis

V_alue of First Day Angiography/Angioplasty I_n Evolving N_on-ST Segment Elevation Myocardial Infarction: An O_pen Multicenter Randomized Trial. The VINO Study

Myocardial Reperfusion Injury

Early invasive versus conservative strategies for unstable angina & non-ST-elevation myocardial infarction in the stent era

Impaired vascular function in patients with Fontan circulation

Third Universal Definition of Myocardial Infarction

Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation

Factors associated with failure to identify the culprit artery by the electrocardiogram in inferior ST-elevation myocardial infarction

Clopidogrel Effect on Platelet REactivity in Patients With Stent Thrombosis

Clopidogrel 150 mg/day to Overcome Low Responsiveness in Patients Undergoing Elective Percutaneous Coronary Intervention

Doppler Tissue Imaging: A Noninvasive Technique for Evaluation of Left Ventricular Relaxation and Estimation of Filling Pressures

Proposed Mayo Clinic criteria for the diagnosis of Tako-Tsubo cardiomyopathy and long-term prognosis

Exercise-induced T-wave normalization predicts recovery of regional contractile function after anterior myocardial infarction

The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes

2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Prognostic Significance of Admission Heart Failure in Patients With Non–ST-Elevation Acute Coronary Syndromes (from the Canadian Acute Coronary Syndrome Registries)

Vasodilator and inotropic drugs for the treatment of chronic heart failure: Distinguishing hype from hope

Outcome of Patients with Acute Myocardial Infarction Who Are Ineligible for Thrombolytic Therapy

Neurohumoral Features of Myocardial Stunning Due to Sudden Emotional Stress

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)

Reversible Myocardial Contraction Abnormalities in Patients With an Acute Noncardiac Illness

Hypertension and Smoking Are Associated With Reduced Regional Left Ventricular Function in Asymptomatic Individuals

Impact of Platelet Reactivity After Clopidogrel Administration on Drug-Eluting Stent Thrombosis

Gender differences in management and outcomes in patients with acute coronary syndromes: results on 20 290 patients from the AMIS Plus Registry

Prediction of Cardiovascular Outcomes With Left Atrial Size

Switching directly to prasugrel from clopidogrel results in greater inhibition of platelet aggregation in aspirin-treated subjects

Recommendations for chamber quantification☆

Bias in meta-analysis detected by a simple, graphical test

Infarct size and magnesium: insights into LIMIT-2 and ISIS-4 from experimental studies

Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study

Myocarditis

Early and Late Benefits of Prasugrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

Revascularization among patients with severe left ventricular dysfunction: a meta‐analysis of observational studies

Muscle cramps and magnesium deficiency: case reports.

Ticagrelor Versus Clopidogrel in Acute Coronary Syndromes in Relation to Renal Function

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

Randomized Comparison of Prasugrel (CS-747, LY640315), a Novel Thienopyridine P2Y ₁₂ Antagonist, With Clopidogrel in Percutaneous Coronary Intervention

Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)

Platelet Function Testing in Cardiovascular Diseases

Contribution of Gene Sequence Variations of the Hepatic Cytochrome P450 3A4 Enzyme to Variability in Individual Responsiveness to Clopidogrel

Magnesium in Man: Implications for Health and Disease

Tissue Plasminogen Activator for Acute Ischemic Stroke

Myocardial Fatty Acid Metabolism in Health and Disease

Inhibition of Platelet Aggregation by AZD6140, A Reversible Oral P2Y12Receptor Antagonist, Compared With Clopidogrel in Patients With Acute Coronary Syndromes

Diabetes and Antiplatelet Therapy in Acute Coronary Syndrome

Transcatheter Mitral-Valve Repair in Patients with Heart Failure

ACC/AHA guidelines for coronary angiography11“ACC/AHA Guidelines for Coronary Angiography” was approved by the American College of Cardiology Board of Trustees in October 1998 and by the American Heart Association Science Advisory and Coordinating Committee in December 1998.22When citing this document, the American College of Cardiology and the American Heart Association request that the following format be used: Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, Legako RD, Leon DF, Murray JA, Nissen SD, Pepine CJ, Watson RM. ACC/AHA guidelines for coronary angiography: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography). J Am Coll Cardiol1999;33:1756–82433This document is available on the websites of the ACC (www.acc.org) and the AHA (www.americanheart.org). Reprints of this document (the complete guidelines) are available for $5 each by calling 800-253-4636 (US only) or writing the American College of Cardiology, Educational Services, 9111 Old Georgetown Road, Bethesda, MD 20814-1699. Ask for reprint No. 71-0164. To obtain a reprint of the shorter version (executive summary and summary of recommendations) published in the May 4, 1999, issue of Circulation, ask for reprint No. 71-0163. To purchase additional reprints (specify version and reprint number): up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 214-706-1466, fax 214-691-6342, or e-mail pubauth@heart.org

Response to Ticagrelor in Clopidogrel Nonresponders and Responders and Effect of Switching Therapies

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death

Stress-Related Cardiomyopathy Syndromes

Paradoxic elevation of fibrinopeptide A after streptokinase: Evidence for continued thrombosis despite intense fibrinolysis

2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease

Survival and Cardiovascular Outcomes of Patients With Secondary Mitral Regurgitation

Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets

Safety and Tolerability of Antiplatelet Therapies for the Secondary Prevention of Atherothrombotic Disease

Intravenous magnesium for acute myocardial infarction

Left atrial volume and function in patients following ST elevation myocardial infarction and the association with clinical outcome: a cardiovascular magnetic resonance study

2012 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction (Updating the 2007 Guideline and Replacing the 2011 Focused Update)

Comparison of Platelet Function Tests in Predicting Clinical Outcome in Patients Undergoing Coronary Stent Implantation

Evidence for reduced fibrinolytic activity in unstable angina at rest. Clinical, biochemical, and angiographic correlates.

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Prasugrel

2014 ACC/AHA/AATS/PCNA/SCAI/STS Focused Update of the Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease

Fourth Universal Definition of Myocardial Infarction (2018)

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel

Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction.

Transient giant negative T wave in acute anterior myocardial infarction predicts R wave recovery and preservation of left ventricular function.

Magnesium Sulfate Reduces Myocardial Infarct Size When Administered Before but Not After Coronary Reperfusion in a Canine Model

Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial

An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction

Fourth universal definition of myocardial infarction (2018)

Recommendations for the Standardization and Interpretation of the Electrocardiogram

ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”

Dose Effect of Clopidogrel Reloading in Patients Already on 75-mg Maintenance Dose

Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy.

2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes

Clinical Features and Outcomes of Women With Unstable Ischemic Heart Disease

Part 14: Pediatric Advanced Life Support

Monitoring of Clopidogrel Action: Comparison of Methods

Pharmacodynamic effect and clinical efficacy of clopidogrel and prasugrel with or without a proton-pump inhibitor: an analysis of two randomised trials

Clopidogrel Response Variability and Future Therapies

Recommendations for the standardization and interpretation of the electrocardiogram

Coronary Thrombolysis for the Elderly?

Regulation of cation channels in cardiac and smooth muscle cells by intracellular magnesium

Stress-induced ST-segment elevation in patients without prior Q-wave myocardial infarction

Long-Term Outcome of Intravenous Magnesium Therapy in Thrombolysis-Ineligible Acute Myocardial Infarction Patients

Incidence of left ventricular thrombi formation after thrombolytic therapy with recombinant tissue plasminogen activator, heparin, and aspirin in patients with acute myocardial infarction

Comparison of Short- and Long-Term Prognosis in Patients With Anterior Wall Versus Inferior or Lateral Wall Non-Q-Wave Acute Myocardial Infarction

Smoking and prognosis after acute myocardial infarction in the thrombolytic era (Israeli thrombolytic national survey)

The rationale of magnesium as alternative therapy for patients with acute myocardial infarction without thrombolytic therapy

Comparison of myocardial revascularization without cardiopulmonary bypass to standard open heart technique in patients with left ventricular dysfunction1

The Impact of Renal Dysfunction on Outcomes in the ExTRACT-TIMI 25 Trial

Prognostic significance of mild mitral regurgitation by color Doppler echocardiography in acute myocardial infarction

Left ventricular apical ballooning: Not an uncommon variant of acute myocardial infarction in women

Outcome of Myocardial Infarction in Patients Treated with Aspirin Is Enhanced by Pre-Hospital Administration

The significance of persistent ST elevation versus early resolution of ST segment elevation after primary PTCA

Management and Outcomes of Elderly Women and Men With Acute Coronary Syndromes in 2000 and 2002

Randomized controlled trial of late in-hospital angiography and angioplasty versus conservative management after treatment with recombinant tissue-type plasminogen activator in acute myocardial infarction

Hemodynamic effects of oral isosorbide‐5‐mononitrate and dinitrate in ischemic heart failure

Long-term prognostic significance of left atrial volume in acute myocardial infarction

Q wave and non-Q wave myocardial infarction after thrombolysis

Prognostic significance of second-degree atrioventricular block in inferior wall acute myocardial infarction

Effect on survival of acute myocardial infarction in Killip classes II or III patients undergoing invasive coronary procedures

Early T wave inversion after thrombolytic therapy predicts better coronary perfusion: Clinical and angiographic study

Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction

Impact of the Metabolic Syndrome on the Clinical Outcomes of Non-Clinically Diagnosed Diabetic Patients With Acute Coronary Syndrome

Beneficial effect of magnesium sulfate in acute myocardial infarction

Comparison of incidence of cardiac rupture among patients with acute myocardial infarction treated by thrombolysis versus percutaneous transluminal coronary angioplasty

Primary angioplasty with routine stenting compared with thrombolytic therapy in elderly patients with acute myocardial infarction

Significance of ST Segment Elevations in Posterior Chest Leads (V7to V9) in Patients With Acute Inferior Myocardial Infarction: Application for Thrombolytic Therapy

Complete atrioventricular block complicating inferior acute wall myocardial infarction: Short- and long-term prognosis

Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads V7–9

Timing of aspirin administration as a determinant of survival of patients with acute myocardial infarction treated with thrombolysis

External counterpulsation therapy improves endothelial function in patients with refractory angina pectoris

Underuse of Standard Care and Outcome of Patients with Acute Myocardial Infarction and Chronic Renal Insufficiency

Acute myocardial infarction with isolated ST-segment elevation in posterior chest leads: V 7–9

Clopidogrel Resistance Is Associated With Increased Risk of Recurrent Atherothrombotic Events in Patients With Acute Myocardial Infarction

Effect of Ranolazine, an Antianginal Agent With Novel Electrophysiological Properties, on the Incidence of Arrhythmias in Patients With Non–ST-Segment–Elevation Acute Coronary Syndrome

Is immunosuppressive treatment an option for myocarditis?

Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention

Enhancement of thrombolysis with tissue-type plasminogen activator by pretreatment with heparin.

Shortened Doppler-derived mitral A wave deceleration time: An important predictor of elevated left ventricular filling pressure

Mortality and morbidity rates of patients older and younger than 75 years with acute myocardial infarction treated with intravenous streptokinase

Inferior ST segment changes during acute anterior myocardial infarction: A marker of the presence or absence of concomitant inferior wall ischemia